Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
UMP Healthcare Holdings Limited ( (HK:0722) ) has provided an announcement.
UMP Healthcare Holdings Limited announced its interim results for the six months ending December 31, 2024, revealing a slight decrease in revenue by 1.2% compared to the previous year. Despite this, the company saw a significant increase in EBITDA by 17% and profit for the period rose by 45.7%, indicating improved operational efficiency. The earnings per share increased by 14.8%, and the interim dividend per share rose by 7.7%, reflecting a strong financial performance. The company’s cash and bank balances also grew by 18.4%, highlighting a robust financial position.
More about UMP Healthcare Holdings Limited
UMP Healthcare Holdings Limited operates in the healthcare industry, providing medical and healthcare services. The company focuses on offering a range of services including medical consultations, diagnostic and specialty services, primarily in Hong Kong and Mainland China.
YTD Price Performance: 2.44%
Average Trading Volume: 57,319
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$336.4M
Learn more about 0722 stock on TipRanks’ Stock Analysis page.